About My Health Careers Internship MedBlogs Contact us

New Drug, Sofosbuvir, Found Very Efficient in Treating Chronic Hepatitis C Virus Infection

by Raja Nandhini on May 3, 2013 at 11:26 AM
Font : A-A+

New Drug, Sofosbuvir, Found Very Efficient in Treating Chronic Hepatitis C Virus Infection

Sofosbuvir, a drug developed by Gilead Sciences, has been proven to be very effective in treating various subtypes of chronic Hepatitis C Virus Infection; the drug is currently in its phase III clinical trials.

Researchers conducted two open label trials to compare the efficacy of the new drug with the current treatment regimen of ribavirin and peginterferon alfa-2a. Patients enrolled in the study were not treated previously for HCV infection and 20% of them had liver cirrhosis.


The first study involved 327 patients infected with HCV genotype 1, 4, 5, or 6. All patients in this trial received sofosbuvir, ribavirin, and peginterferon alfa-2a for 12 weeks.

The other study was a randomized one and involved 499 patients with HCV genotype 2 or 3 infection. Patients received either 12 weeks of sofosbuvir plus ribavirin or 24 weeks of peginterferon alfa-2a plus ribavirin.

Serum HCV RNA levels were measured and IL28B genotyping was done to evaluate the response to HCV therapy. By the end of fourth week, 99% of patients who received sofosbuvir in both the trials recorded a drastic reduction in serum HCV RNA levels.

In the first single-group study, 89% of patients with HCV genotype 1 and 96% of patients with HCV genotype 4 had sustained virologic response i.e. undetectable levels of serum HCV RNA levels 12 weeks after the treatment.

In the randomized study, 67% of patients from each group had sustained virologic response. However, the response rate among patients with genotype 2 infection was higher than among those with genotype 3 infection and taking sofosbuvir-ribavirin combination of drugs.

Adverse effects like anemia and other Hematologic disorders were more common among patients on peginterferon-ribavirin regimen than those on sofosbuvir-ribavirin treatment. Researchers could not detect any viral resistant mutations in the blood samples of patients who had a relapse. This necessitates further research to identify the cause of relapse.

Authors thus conclude that the efficacy of Sofosbuvir is impressive and the drug regimen needs further analysis to improve the response rates in patients with genotype 3 infection.

Reference : Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection; Eric Lawitz et al; NEJM April 2013.

Source: Medindia

News A-Z
News Category
What's New on Medindia
First Dose of COVID-19 Vaccines May Improve Mental Health
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chicken Pox Hepatitis A Hepatitis B Shigellosis Vasculitis Silent Killer Diseases Liver Flu Aplastic Anemia Hepatitis C 

Recommended Reading
Hepatitis C
Hepatitis C is a contagious viral disease affecting the liver that is caused by the hepatitis C ......
Junk Foods and Hepatitis C
Researches show that the effects of consuming fast foods could be as bad as hepatitis C....
New Study on Hepatitis C Drug Treatment in Vivo and in Vitro
Hepatitis C virus (HCV) infection is the primary cause of liver cirrhosis and liver cancer ......
Aplastic Anemia
Aplastic anemia (AA) is a term that refers to a condition where the body fails to produce enough blo...
Chicken Pox
Chicken pox is an acute and highly contagious viral infection caused by the varicella zoster virus....
Hepatitis A
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. H...
Hepatitis B
Hepatitis B is inflammation of the liver due to infection with the hepatitis B virus....
Shigellosis or Bacillary Dysentery is a common cause of gastro-enteritis worldwide and can cause blo...
Vasculitis is an inflammation of the blood vessels of the body that can affect people of all ages; i...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use